Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses

Infection and Immunity

Volumn 73, Issue 6, 2005, Pages 3787-3789

  Da Costa Pinheiro, Paulo Henrique ^a,b   De Souza Dias, Suzana ^a   Dantas Eulálio, Kelsen ^c   Mendonça, Ivete L ^c   Katz, Simone ^a   Barbiéri, Clara Lúcia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade NOVAFAPI   (Brazil)

^c FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT ENZYME;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOG; ENZYME ISOLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA CHAGASI; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CYSTEINE ENDOPEPTIDASES; DOGS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 19744368943     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.6.3787-3789.2005     Document Type: Article

References (16)

1. Bacellar, O., M. Barral-Neto, R. Badaró, and E. M. Carvalho. 1991. Gamma interferon production by lymphocytes from children infected with L. chagasi (L.) chagasi. Braz. J. Med. Biol. Res. 24:791-795.
2. Barbiéri, C. L., A. I. Doine, and E. Freymüller. 1990. Lysosomal depletion in macrophages from spleen and foot lesions of Leishmania-infected hamster. Exp. Parasitol. 71:218-228.
3. Carvalho, E. M., O. Bacellar, C. Brownell, T. Regis, R. L. Coffman, and S. G. Reed. 1994. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152:5949-5956.
4. Carvalho, E. M., A. Barral, D. Pedral-Sampaio, M. Barral-Netto, R. Badaró, H. Rocha, and W. D. Johnson. 1992. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J. Infect. Dis. 165:535-540.
5. Carvalho, E. M., R. S. Teixeira, and W. D. Johnson, Jr. 1981. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect. Immun. 22:649-656.
6. Dias, S. S., P. H. C. Pinheiro, S. Katz, M. R. M. dos Santos, and C. L. Barbiéri. 2005. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis. Am. J. Med. Trop. Hyg. 72:126-132.
7. Gama, M. E. A., J. M. L. Costa, J. C. R. Pereira, C. M. C. Gomes, and C. E. P. Corbett. 2004. Serum cytokine profile in the subclinical form of visceral leishmaniasis. Braz. J. Med. Biol. Res. 37:129-136.
8. Ghalib, H. W., M. R. Piuvezam, Y. A. Sheiky, M. Siddig, F. A. Hashim, A. M. el-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Investig. 92:324-329.
9. Nakhaee, A., T. Taheri, M. Taghikhani, M. Mohebali, A.-H. Salmanian, N. Fasel, and S. Rafati. 2004. Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population. Vet. Parasitol. 119:107-123.
10. Omara-Opyene, A. L., and L. Gedamu. 1997. Molecular cloning, characterization and overexpression of two distinct cysteine protease cDNAs from Leishmania donovani chagasi. Mol. Biochem. Parasitol. 90:247-267.
11. Panaro, M. A., A. Acquafredda, S. Lisi, D. D. Lofrumento, T. Trotta, R. Satalino, M. Saccia, V. Mitolo, and O. Brandonisio. 1999. Inducible nitric oxide synthase and nitric oxide production in Leishmania infantum-infected human macrophages stimulated with interferon-gamma and bacterial lipopolysaccharide. Int. J. Clin. Lab. Res. 29:122-127.
12. Rafati, S., A. Nakhaee, T. Taheri, A. H. Ghashghaii, A. H. Salmanian, M. Jimenez, M. Mohebali, S. Masina, and N. Fasel. 2003. Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis. Exp. Parasitol. 103:143-151.
13. Rezai, H. R., S. M. Ardehali, G. Amirhakimi, and A. Kharazmi. 1978. Immunological features of kala-azar. Am. J. Trop. Med. Hyg. 27:1079-1083.
14. Sang, D. K., J. H. Ouma, C. C. John, C. C. Whalen, C. L. King, A. A. F. Mahmoud, and F. P. Heinzel. 1999. Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis. J. Infect. Dis. 179:743-746.
15. Santos-Gomes, G. M., R. Rosa, C. Leandro, S. Cortes, P. Romão, and H. Silveira. 2002. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet. Immunol. Immunopathol. 88:21-30.
16. Voldoukis, I., J. C. Drapier, A. K. Nüssler, Y. Tselentis, O. A. Silva, M. Gentilini, D. M. Mossalayi, L. Monjour, and B. Dugas. 1996. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrob. Agents Chemother. 40:253-256.